Waud Capital Partners latest leadership promotions highlight a growing influence in healthcare supply chain management and specialized medical services. Under experienced investor leadership, the Chicago-based private equity firm has strengthened its expertise in these critical sectors through strategic promotions of seasoned healthcare investors.
Kyle Lattner’s elevation to partner represents a significant milestone in the firm’s healthcare strategy. Since joining in 2013, Lattner has developed deep expertise in medical device services and supply chain operations, building on successful healthcare platforms within the portfolio. His recent leadership in the Senior Helpers and Mopec Group investments demonstrates the firm’s commitment to building comprehensive healthcare service platforms.
Tim Cremieux’s promotion to partner further enhances the company’s strategic capabilities. After joining in 2017, Cremieux has made substantial contributions to the firm’s pharmaceutical services strategy. His recent leadership of the PharmAlliance platform investment exemplifies the focus on building efficient healthcare supply networks. Cremieux also oversees portfolio companies Apotheco and PromptCare, adding depth to the firm’s healthcare distribution expertise.
Strategic growth and leadership have guided the firm’s evolution from a one-person operation to its current position managing $4.6 billion in assets. The focus on supply chain excellence and medical services has become increasingly central to this success.
The healthcare team gains additional strength with Mike Lehman’s promotion to principal. Since 2021, Lehman has supported key investments including Unifeye Vision Partners and the firm’s newest addition to its healthcare portfolio, Mopec Group. His advancement reinforces the firm’s commitment to developing specialized expertise across its healthcare investment platform.
Chris Graber, Partner and Head of the Healthcare Group, emphasizes the strategic importance of these promotions: “All of these new Partners have demonstrated extraordinary leadership, delivering value, insights and expertise to their portfolio companies and contributing to the continued success of Waud Capital.”
This enhanced leadership team positions the firm to capitalize on emerging opportunities in healthcare supply chain and medical services. The investment strategy, typically deploying $75 million to $200 million in growth-oriented companies, has supported the completion of more than 480 investments since its founding.
As healthcare delivery continues to evolve, the strengthened expertise in supply chain management and medical services provides a strong foundation for future growth. The focus on building market-leading companies through specialized sector knowledge remains central to its investment approach as it moves into 2025.
